Trademark: PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Click here to search for trademarks similar to PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Proof of use for PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
We do not have any records of a proof of use for PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY at this moment.
Click here to add a proof of use for PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Possible trademark infringements of PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
Basic Information about PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY
- Serial Number
- 87982664
- Filing Date
- 23 Jun 2017
- Registration Number
- 6008629
- Registration Date
- 10 Mar 2020
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY on the blockchain with WikiTrademarks.io.
- First use of PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY anywhere
- PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY was first used on 10 Oct 2019 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 042
- US Codes
- 100; 101
Who owns PLEXXIKON SCAFFOLD-BASED DRUG DISCOVERY?
Correspondent
- Harold Milstein
- Sheppard Mullin Richter & Hampton LLP
- 1540 El Camino Real, Suite 120
- Menlo Park CA 94025
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io